Notice of Changes to the Package Insert for Betahistine Hydrochlo

Keywords:

Product News

Notice of Changes to the Package Insert for Betahistine Hydrochloride Tablets


In placebo-controlled clinical trials, patients treated with betahistine experienced the following adverse reactions (very common ≥1/10; common ≥1/100 to <1/10; uncommon ≥1/1000 to <1/100; rare ≥1/10000 to <1/1000; very rare <1/10000).